YP05002 Tablets for Weight Management

A Study of YP05002 in Healthy Participants

Recruiting Phase 1 Interventional Study
Weight Management
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Trial phase
Phase 1
Study type
Interventional
Purpose
Treatment
Participants needed
76 (estimated)
Sponsor
Yaopharma Co., Ltd. · Industry
Who this trial is looking for

This trial is looking for healthy adults aged 18-65 who want to help test how a new tablet works for weight management. Participants will take either the new tablet or a placebo and attend regular study visits to check their health and safety.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am healthy and aged 18-65
  • I can follow the study plan and attend all visits

You may not be able to join if

  • I have any significant active or chronic disease
  • I have taken drugs that affect absorption or digestion in the last 14 days
  • I have had any serious medical condition that could affect my safety
  • I have had cancer in the last 5 years
  • I have been diagnosed with any type of pancreatitis

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This is a phase I, randomized, double-blind, placebo-controlled, single and multiple ascending dose study to evaluate the safety, tolerability, pharmacokinetics, efficacy, food effect of YP05002 Tablets in healthy participants

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Willing and able to comply with all scheduled visits, treatment plan, laboratory tests, and other study procedures. 2. Healthy male and female participants aged 18-65 years (both inclusive).No restrictions on race. 3. In good health as determined by the Investigator, with no …
Contacts

Yalei Xie

+86 23 63211443

xieyl@yaopharma.com

CONTACT